B-cell–specific STAT3 deficiency: Insight into the molecular basis of autosomal-dominant hyper-IgE syndrome - 09/11/16

| This work was supported by grants awarded by the National Health and Medical Research Council (NHMRC) of Australia (grant nos. 1016953, 1066694, and 1027400 to S.G.T. and E.K.D.). A.K. is supported by a Postgraduate scholarship (1038881) and R.B. and S.G.T. by Principal Research Fellowships (1042925, 1105877) from the NHMRC. |
|
| Disclosure of potential conflict of interest: A. Kane has received research support from the National Health and Medical Research Council (NHMRC). R. Brink has received research support from NHMRC Australia. S. G. Tangye has received research support from the NHMRC; has received travel support as an invited speaker at Keystone Symposia; has received consultancy fees from Eli Lilly; and has provided expert witness testimony in a patent dispute. E. K. Deenick has received research support from the NHMRC and has received travel support from Baxalta. A. Lau declares that he has no relevant conflicts of interest. |
Vol 138 - N° 5
P. 1455 - novembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
